Pathophysiology of the Upper Airway in Patients With COPD and Concomitant OSA
Pathophysiology of the Upper Airway in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Concomitant Obstructive Sleep Apnea (OSA)
The purpose of study is to evaluate the physiologic effects of pulmonary tissue/structural changes associated with COPD and upper airway inflammation on upper airway collapsibility. Upper airway collapsibility is closely associated with development of obstructive sleep apnea (OSA), which is a common disease characterized by repetitive collapse of upper airway during sleep, leading to hypoxemia and arousal. OSA has important neurocognitive and cardiovascular consequences, especially in patients with COPD.
Participants in this research study will undergo two overnight sleep studies (PSGs), pulmonary function test, and CT scan of the upper airway and chest. The first sleep study will evaluate the sleep breathing disorder and the second sleep study will measure the upper airway collapsibility, called critical closing pressure (Pcrit). Pcrit is measured by a modified continuous positive airway pressure (CPAP) machine which can provide a wide range of pressures between 20 and -20 cmH2O in order to modify upper airway pressure.
研究概览
详细说明
This is a physiologic study to assess the effects of lower airway and lung tissue changes of COPD on upper airway collapsibility. Increased in lung volume and destruction of alveolar wall in COPD may have opposite and various effects on the upper airway collapsibility, which is an important factor of OSA development.
Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are very common disorders associated with considerable morbidity, mortality, and healthcare costs. The prevalence of both co-existing conditions is estimated to be ~4% of the general population. This COPD-OSA "overlap" syndrome causes more severe hypoxemia than either COPD or OSA alone and has important clinical consequences, including death. COPD is usually excluded in OSA research and OSA is typically excluded or not assessed in studies of COPD; thus, available information about the "overlap" syndrome is limited. Therefore, it is important to identify patients with both COPD and OSA and determine the mechanisms of poor outcomes for these patients in order to optimize therapy. The pathophysiology of the COPD-OSA syndrome is not well understood. The investigators propose to investigate upper airway (UA) anatomic characteristics and collapsibility as potential underlying mechanisms that may help to explain the negative additive effect of having both conditions. The objectives are to study CT measures of airway anatomy and the critical closing pressure of the upper airway (Pcrit), a gold standard measure of upper airway collapsibility, in patients with COPD-OSA compared with COPD only and normal controls. CT scan of upper airway and chest will allow precise measures of upper airway characteristics and COPD associated alveolar and lower airway ch. angesMeasures of upper airway collapsibility will provide us information about the mechanical nature of the airway and if the patients are more likely to have OSA. Subjects with COPD-OSA may exhibit more upper airway inflammation possibly due to their pre-existing COPD disease and the reoccurring opening and closing of the upper airway due to the OSA. Therefore the investigators would like to assess the degree of inflammation in these patients compared to normal controls.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
California
-
San Diego、California、美国、92093
- University of California, San Diego
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria for COPD Subjects:
- Age range 40-70 years.
- Demonstrated moderate to severe COPD as determined by spirometry (post-bronchodilator spirometry FEV1/FVC < 0.70 for diagnosing CODP and FEV1<80% predicted for staging)
- Smoking history of ≥ 10 pack-years
Inclusion Criteria for Control Subjects
- Age range 40-70 years
- Demonstrated no COPD as determined by normal spirometry (post-bronchodilator spirometry FEV1/FVC > 0.70 for diagnosing CODP and FEV1<80% predicted for staging)
- No smoking history as defined by less than 100 cigarettes smoked in a lifetime
Exclusion Criteria for both COPD and Control Subjects:
- Metal objects that may interfere with chest CT quantification including presence of a cardiac pacemaker, defibrillator, metal prosthetic heart valve, metal projectile or metal weapon fragment (bullet, shrapnel, shotgun shot) or metal shoulder prosthesis
Subjects unable to perform spirometry due to:
- chest or abdominal surgery in the past three months
- a heart attack in the last three months
- detached retina or eye surgery in the past three months
- hospitalization for any other heart problem in the past month
- History of hypersensitivity to Afrin, Lidocaine or albuterol
- A psychiatric disorder, other than mild depression; e.g. schizophrenia, bipolar disorder, major depression, panic or anxiety disorders.
- More than 10 cups of beverages with caffeine (coffee, tea, soda/pop) per day
- Pregnancy or suspected pregnancy
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:非随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
有源比较器:COPD Group
Patients who were previously diagnosed of moderate to severe COPD as determined by spirometry.
All patients will have sleep and pulmonary physiologic measurements.
|
Two overnight sleep studies, CT scan of upper airway and chest, pulmonary function test and pharyngeal lavage
|
有源比较器:Normal Control Group
Patients who are healthy, without major medical or sleep problems, and have normal spirometry.
All patients will have sleep and pulmonary physiologic measurements.
|
Two overnight sleep studies, CT scan of upper airway and chest, pulmonary function test and pharyngeal lavage
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Critical closing pressure (PCrit)
大体时间:Baseline
|
Measured during overnight sleep study
|
Baseline
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Pharyngeal lavage cell count distribution
大体时间:Baseline
|
Baseline
|
|
Minimal later airway dimension (mLAT)
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Minimal anteroposterior airway dimension (mAP)
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Minimal cross sectional airway area (mCSA)
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Lateral airway dimension on hard palate/uvula/epiglottis level
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Anteroposterior airway dimension on hard palate/uvula/epiglottis level
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Cross-sectional airway area on hard palate/uvula/epiglottis level
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Distance between the lower edge of the mandible and the lower edge of the hyoid (MH)
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Upper airway length
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Width of hard palate
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Nasophayngeal/retropalatal/retroglossal pharyngeal cavity volume
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Volume within the cervico-mandibular bony frame
大体时间:Baseline
|
Measured from upper airway CT scan
|
Baseline
|
Volume of retropalatal/retroglossal soft tissue
大体时间:Baseline
|
Baseline
|
|
Parapharyngeal fat pad volume
大体时间:Baseline
|
Baseline
|
|
Tongue volume
大体时间:Baseline
|
Baseline
|
|
Emphysema score
大体时间:Baseline
|
Measured from CT chest scan
|
Baseline
|
Emphysema distribution
大体时间:Baseline
|
Measured from CT chest scan
|
Baseline
|
Lower airway wall thickness on chest CT scan
大体时间:Baseline
|
Measured from CT chest scan
|
Baseline
|
Forced expiratory volume in 1 second (FEV1)
大体时间:Baseline
|
Baseline
|
|
Total lung capacity (TLC)
大体时间:Baseline
|
Baseline
|
|
Ratio of residual volume / total lung capacity (RV/TLC)
大体时间:Baseline
|
Baseline
|
|
Diffusing capacity of the lung for carbon monoxide (DLCO)
大体时间:Baseline
|
Baseline
|
合作者和调查者
调查人员
- 首席研究员:Xavier Soler, MD, PhD、University of California, San Diego
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.